Follow

Submissions from 2022

Ticagrelor versus aspirin 2 years after coronary bypass: Observational analysis from the TARGET trial, Alexander Kulik, Amy Abreu, and Viviana Boronat

Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions, Raymond Masa

Submissions from 2021

Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial, Alexander Kulik, Viviana Boronat, and Amy Abreu

Submissions from 2020

PDF

Impact of lipid levels and high-intensity statins on vein graft patency after CABG: Midterm results of the ACTIVE trial, Alexander Kulik, Amy Abreu, and Viviana Boronat
Full Text Restricted – Available from BHSF IP or login only